TY - JOUR
T1 - Hospitalized exacerbations of COPD
T2 - Risk factors and outcomes in the ECLIPSE cohort
AU - ECLIPSE Investigators
AU - Müllerova, Hana
AU - Maselli, Diego J.
AU - Locantore, Nicholas
AU - Vestbo, Jørgen
AU - Hurst, John R.
AU - Wedzicha, Jadwiga A.
AU - Bakke, Per
AU - Agusti, Alvar
AU - Anzueto, Antonio
AU - Ivanov, Yavor
AU - Kostov, Kosta
AU - Bourbeau, Jean
AU - Fitzgerald, Mark
AU - Hernández, Paul
AU - Killian, Kieran
AU - Levy, Robert
AU - Maltais, Francois
AU - O'Donnell, Denis
AU - Krepelka, Jan
AU - Wouters, Emiel F.M.
AU - Quinn, Dean
AU - Kosnik, Mitja
AU - Feschenko, Yuri
AU - Gavrisyuk, Volodymyr
AU - Yashina, Lyudmila
AU - MacNee, William
AU - Singh, S. David
AU - Braman, Sidney
AU - Casaburi, Richard
AU - Celli, Bart
AU - Giessel, Glenn
AU - Gotfried, Mark
AU - Greenwald, Gary
AU - Hanania, Nicola
AU - Mahler, Don
AU - Make, Barry
AU - Rennard, Stephen
AU - Rochester, Carolyn
AU - Scanlon, Paul
AU - Schuller, Dan
AU - Sciurba, Frank
AU - Sharafkhaneh, Amir
AU - Siler, Thomas
AU - Silverman, Edwin
AU - Wanner, Adam
AU - Wise, Robert
AU - Wallack, Richard Zu
N1 - Funding Information:
Dr Wedzicha is currently at the National Heart and Lung Institute, Imperial College London (London, England). Funding/Support: The ECLIPSE study was funded by GlaxoSmithKline. Reproduction of this article is prohibited without written permission from the American College of Chest Physicians. See online for more details.
Publisher Copyright:
© 2015 American College of Chest Physicians.
PY - 2015/4/1
Y1 - 2015/4/1
N2 - OBJECTIVE: Exacerbations of COPD requiring hospital admission have important clinical and societal implications. We sought to investigate the incidence, recurrence, risk factors, and mortality of patients with COPD exacerbations requiring hospital admission compared with those without hospital admission during 3-year follow-up. Patients with COPD (N=2,138) were identified from the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) observational cohort. METHODS: An analysis of time to first event of hospital admission was performed using Kaplan-Meier curves and Cox proportional hazard regression adjusting for possible confounders. RESULTS: Of the 2,138 patients, 670 (31%) reported a total of 1,452 COPD exacerbations requiring hospital admission during the study period; 313 patients (15%) reported multiple events. A prior history ofexacerbation of COPD requiring hospital admission was the factor associated with the highest risk of a new hospitalization for exacerbation (hazard ratio, 2.71; 95% CI, 2.24-3.29; P <.001). Other risk factors included more severe airfl ow limitation, poorer health status, older age, radiologic evidence ofemphysema, and higher WBC count. Having been hospitalized for exacerbation significantly increased the risk of mortality (P , <001). CONCLUSIONS: Exacerbations of COPD requiring hospital admission occur across all stages of airfl ow limitation and are a significant prognostic factor ofreduced survival across all COPD stages. Patients with COPD at a high risk for hospitalization can be identified by their past history for similar events, and other factors, including the severity of airfl ow limitation, poor health status, age, presence ofemphysema, and leukocytosis.
AB - OBJECTIVE: Exacerbations of COPD requiring hospital admission have important clinical and societal implications. We sought to investigate the incidence, recurrence, risk factors, and mortality of patients with COPD exacerbations requiring hospital admission compared with those without hospital admission during 3-year follow-up. Patients with COPD (N=2,138) were identified from the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) observational cohort. METHODS: An analysis of time to first event of hospital admission was performed using Kaplan-Meier curves and Cox proportional hazard regression adjusting for possible confounders. RESULTS: Of the 2,138 patients, 670 (31%) reported a total of 1,452 COPD exacerbations requiring hospital admission during the study period; 313 patients (15%) reported multiple events. A prior history ofexacerbation of COPD requiring hospital admission was the factor associated with the highest risk of a new hospitalization for exacerbation (hazard ratio, 2.71; 95% CI, 2.24-3.29; P <.001). Other risk factors included more severe airfl ow limitation, poorer health status, older age, radiologic evidence ofemphysema, and higher WBC count. Having been hospitalized for exacerbation significantly increased the risk of mortality (P , <001). CONCLUSIONS: Exacerbations of COPD requiring hospital admission occur across all stages of airfl ow limitation and are a significant prognostic factor ofreduced survival across all COPD stages. Patients with COPD at a high risk for hospitalization can be identified by their past history for similar events, and other factors, including the severity of airfl ow limitation, poor health status, age, presence ofemphysema, and leukocytosis.
UR - http://www.scopus.com/inward/record.url?scp=84927138885&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84927138885&partnerID=8YFLogxK
U2 - 10.1378/chest.14-0655
DO - 10.1378/chest.14-0655
M3 - Article
C2 - 25356881
AN - SCOPUS:84927138885
SN - 0012-3692
VL - 147
SP - 999
EP - 1007
JO - CHEST
JF - CHEST
IS - 4
ER -